![](https://ml.globenewswire.com/media/da63f6aa-3c32-4a68-9476-7d4e40cec64d/small/lsta-logo-final-6-8-22-logo-color-transparant-background-002.jpg)
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX based therapies in pancreatic, colon and appendiceal cancers BASKING RIDGE, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: …